Deal Inked for Oral Cancer Vaccine Research
UbiVac and Janssen Biotech will collaborate in preclinical and clinical versions of UbiVac’s proprietary DRibble immunotherapy for use in preclinical studies of oral.
Dentistry Today is The Nation’s Leading Clinical News Magazine for Dentists. Here you can get the latest dental news from the whole world quickly.
UbiVac and Janssen Biotech will collaborate in preclinical and clinical versions of UbiVac’s proprietary DRibble immunotherapy for use in preclinical studies of oral.
Shrimp aren’t just popular on the menu. They’re also part of new technology crafted by researchers at the University of North Carolina (UNC).
More than 47,000 Americans will be diagnosed with oral or pharyngeal cancer this year, according to the National Cancer Institute. When caught early,.
Nearly 45,750 Americans will be diagnosed with oral or pharyngeal cancer this year, according to the Oral Cancer Foundation. In 5 years, only.
Today’s oral cancer detection products typically rely on revealing abnormalities or detecting HPV. Yet these tests aren’t necessarily accurate or timely, discovering dangers.
There’s no good news when it comes to adolescents and e-cigarettes. Teens who “vape” are more likely to try combustible tobacco in the.
Vigilant Biosciences has struck a three-year deal with Crown Dental + Medical Limited to distribute the OncAlert Oral Cancer Risk Assessment System in New Zealand..
Recent awards from the National Institutes of Health will be used to help researchers at New York University and the University of Pittsburgh.
A new discovery may change the way oral cancer is treated. An abnormal immune response could be one of the causes of metastases.
LED Dental Inc. (“LED Dental” or the “Company”), today announced that it is bestowing a gift of $8,000 on the University of British.